Clinical review report Dolutegravir (Tivicay)
The objective of this review is to evaluate the beneficial and harmful effects of Dolutegravir (DTG) at recommended doses in combination with other antiretroviral drugs for the treatment of HIV infection in antiretroviral drugs(ART)-naive and ART-experienced patients.
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa, Ontario :
Canadian Agency for Drugs and Technologies in Health
2014.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820283206719 |
| Sumario: | The objective of this review is to evaluate the beneficial and harmful effects of Dolutegravir (DTG) at recommended doses in combination with other antiretroviral drugs for the treatment of HIV infection in antiretroviral drugs(ART)-naive and ART-experienced patients. |
|---|---|
| Descripción Física: | 1 online resource (1 PDF file (xii, 84 pages)) : illustrations |
